Through bioinformatics analysis and in vitro experiments, we revealed that miR-129-5p, a differentially expressed miRNA between the ABC and GCB subtypes of DLBCL, promoted apoptosis and inhibited proliferation and immune escape of DLBCL through targeted regulation of ARID3A. The gene discussed is ARID3A; the disease is diffuse large B-cell lymphoma.